Three inactivated-virus, gene- and vector-based vaccines protected rhesus monkeys from a Zika challenge, a study yesterday in Science noted. The promising outcomes set the stage for trials involving human subjects.
OSAP Disclaimer | Please notify our webmaster of any problems with this website. OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.